Cisblok 20 (Cisatracurium Besylate USP Vials) 2mg/mlx10ml

Cisblok 20 contains Cisatracurium Besylate USP, a neuromuscular blocking agent available in 2mg/ml vials. Used for muscle relaxation during surgical procedures and intensive care. Store at 2-8°C to maintain potency and stability. Consult a healthcare professional for suitability.

Strength

2mg/mlx10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

ABBOTT INDIA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cisblok 20 is used to provide muscle relaxation during surgical procedures, including intubation and mechanical ventilation. It is also used in intensive care settings to facilitate patient-ventilator synchrony. This medication helps relax muscles by blocking nerve signals, making it easier to manage airway and breathing support. It is not a pain reliever or sedative.

Side Effects

Cisblok 20 works by temporarily blocking nerve signals to muscles, causing relaxation and paralysis. The effects are dose-dependent and reversible with appropriate reversal agents. Patients may experience a gradual return of muscle function as the medication wears off. It does not affect consciousness or pain perception.

Precautions & Warnings

Cisblok 20 should only be administered by trained healthcare professionals in a controlled setting. It requires careful monitoring of respiratory function and muscle activity. Patients with neuromuscular disorders or electrolyte imbalances may need adjusted dosing. Always inform your healthcare provider about your medical history before use.

Avoid Interactions

Cisblok 20 may interact with other medications that affect muscle function or nerve signaling, such as certain antibiotics or anesthetics. Combining it with drugs that enhance neuromuscular blockade can prolong its effects. Alcohol and sedatives may increase drowsiness. Always disclose all medications to your healthcare provider.

References

Frequently Asked Questions

Cisblok 20 is used to relax muscles during surgery or intensive care, aiding intubation and mechanical ventilation.

It is administered intravenously by healthcare professionals in a clinical setting.

No, it requires professional administration and monitoring in a healthcare facility.

Possible side effects include muscle weakness, low blood pressure, or allergic reactions.

No, it is a neuromuscular blocking agent and does not relieve pain.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.